Furthermore, inhibiting BACH1 downstream targets such as mitochondrial metabolic pathways, glycolysis pathways, heme regulatory pathways, and redox homeostasis might be a highly insightful approach to manage metastatic cancer in a complex and context-dependent tumor microenvironment (Figure 4). This evidence concerns the gene BACH1 and metastatic malignant neoplasm.